Health4Men News

HIV patients may soon get help from an unlikely source: a molecule used to enhance the flavors of soy sauce.

HIV infection is associated with an increased risk of melanoma, according to the results of a meta-analysis published in PLOS ONE. Overall, people living with HIV had a 26% increase in their relative risk of melanoma compared to the general population, the risk increasing by 50% for white-skinned people with HIV. The increased risk was statistically significant in white-skinned people diagnosed with HIV and of borderline statistical significance for all people diagnosed with HIV.

A team of scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by antibodies in a way that neutralizes a wide variety of HIV strains.

Tenofovir used as a single agent for pre-exposure prophylaxis (PrEP) may be as effective as the Truvada (tenofovir/emtricitabine) coformulation for preventing HIV infection, which, if confirmed, could have implications for cost and access worldwide.

In Africa, both HIV and HPV are most frequently transmitted through sexual contact.  Although much attention is paid to the AIDS epidemic in Africa, HPV-related cancers, particularly in people with HIV, can be as fatal as AIDS.

Here’s a look at some of the HIV cure headlines over the past couple months. The ever-growing momentum towards a cure, particularly funding for cure initiatives, is encouraging.

It’s the Truvada conundrum: A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay sex without using condoms.

An almost entirely unreported study about anal sex and pain shows how little we really know about it